Global Neuromodulation Devices and Implantable Infusion Pumps Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

Global Neuromodulation Devices and Implantable Infusion Pumps Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

Table of Contents
1 Study Coverage
1.1 Neuromodulation Devices and Implantable Infusion Pumps Product Introduction
1.2 Market by Type
1.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size Growth Rate by Type
1.2.2 Spinal Cord Stimulation
1.2.3 Deep Brain Stimulation
1.2.4 Sacral Nerve Stimulation
1.2.5 Vagal Nerve Stimulation
1.2.6 Gastric Stimulation
1.2.7 Transcranial Magnetic Stimulation
1.2.8 Transcutaneous Electrical Stimulation
1.2.9 Other
1.3 Market by Application
1.3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size Growth Rate by Application
1.3.2 Parkinson's Disease
1.3.3 Epilepsy
1.3.4 Pain
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size Estimates and Forecasts
2.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue 2016-2027
2.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales 2016-2027
2.2 Neuromodulation Devices and Implantable Infusion Pumps Market Size by Region: 2021 Versus 2027
2.3 Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (2016-2027)
2.3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Region: 2016-2021
2.3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Region (2022-2027)
2.3.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Region (2016-2027)
2.4 Neuromodulation Devices and Implantable Infusion Pumps Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region: 2016-2021
2.4.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Forecast by Region (2022-2027)
2.4.3 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Region (2016-2027)
3 Global Neuromodulation Devices and Implantable Infusion Pumps by Manufacturers
3.1 Global Top Neuromodulation Devices and Implantable Infusion Pumps Manufacturers by Sales
3.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Manufacturer (2016-2021)
3.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Neuromodulation Devices and Implantable Infusion Pumps Manufacturers by Revenue
3.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Manufacturer (2016-2021)
3.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Share by Manufacturer (2016-2021)
3.3 Global Neuromodulation Devices and Implantable Infusion Pumps Price by Manufacturer (2016-2021)
3.4 Competitive Landscape
3.4.1 Key Neuromodulation Devices and Implantable Infusion Pumps Manufacturers Covered: Ranking by Revenue
3.4.2 Global Neuromodulation Devices and Implantable Infusion Pumps Market Concentration Ratio (CR5 and HHI) & (2016-2021)
3.4.3 Global Neuromodulation Devices and Implantable Infusion Pumps Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base Distribution, Product Type
3.5.1 Neuromodulation Devices and Implantable Infusion Pumps Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Product Type
3.5.3 Date of International Manufacturers Enter into Neuromodulation Devices and Implantable Infusion Pumps Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Medtronic
4.1.1 Medtronic Corporation Information
4.1.2 Medtronic Description, Business Overview
4.1.3 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Products Offered
4.1.4 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2016-2021)
4.1.5 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Revenue by Product
4.1.6 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application
4.1.7 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Revenue by Geographic Area
4.1.8 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Revenue by Sales Channel
4.1.9 Medtronic Recent Development
4.2 Boston Scientific Corporation
4.2.1 Boston Scientific Corporation Corporation Information
4.2.2 Boston Scientific Corporation Description, Business Overview
4.2.3 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Products Offered
4.2.4 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2016-2021)
4.2.5 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Revenue by Product
4.2.6 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application
4.2.7 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Revenue by Geographic Area
4.2.8 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Revenue by Sales Channel
4.2.9 Boston Scientific Corporation Recent Development
4.3 St. Jude Medical
4.3.1 St. Jude Medical Corporation Information
4.3.2 St. Jude Medical Description, Business Overview
4.3.3 St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Products Offered
4.3.4 St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2016-2021)
4.3.5 St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Revenue by Product
4.3.6 St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application
4.3.7 St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Revenue by Geographic Area
4.3.8 St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Revenue by Sales Channel
4.3.9 St. Jude Medical Recent Development
4.4 Synapse Biomedical
4.4.1 Synapse Biomedical Corporation Information
4.4.2 Synapse Biomedical Description, Business Overview
4.4.3 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Products Offered
4.4.4 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2016-2021)
4.4.5 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Revenue by Product
4.4.6 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application
4.4.7 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Revenue by Geographic Area
4.4.8 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Revenue by Sales Channel
4.4.9 Synapse Biomedical Recent Development
4.5 Nevro Corporation
4.5.1 Nevro Corporation Corporation Information
4.5.2 Nevro Corporation Description, Business Overview
4.5.3 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Products Offered
4.5.4 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2016-2021)
4.5.5 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Revenue by Product
4.5.6 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application
4.5.7 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Revenue by Geographic Area
4.5.8 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Revenue by Sales Channel
4.5.9 Nevro Corporation Recent Development
4.6 Neuropace
4.6.1 Neuropace Corporation Information
4.6.2 Neuropace Description, Business Overview
4.6.3 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Products Offered
4.6.4 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2016-2021)
4.6.5 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Revenue by Product
4.6.6 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application
4.6.7 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Revenue by Geographic Area
4.6.8 Neuropace Recent Development
4.7 Cyberonics
4.7.1 Cyberonics Corporation Information
4.7.2 Cyberonics Description, Business Overview
4.7.3 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Products Offered
4.7.4 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2016-2021)
4.7.5 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Revenue by Product
4.7.6 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application
4.7.7 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Revenue by Geographic Area
4.7.8 Cyberonics Recent Development
4.8 Autonomic Technologies
4.8.1 Autonomic Technologies Corporation Information
4.8.2 Autonomic Technologies Description, Business Overview
4.8.3 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Products Offered
4.8.4 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2016-2021)
4.8.5 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Revenue by Product
4.8.6 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application
4.8.7 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Revenue by Geographic Area
4.8.8 Autonomic Technologies Recent Development
4.9 Avery Biomedical
4.9.1 Avery Biomedical Corporation Information
4.9.2 Avery Biomedical Description, Business Overview
4.9.3 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Products Offered
4.9.4 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2016-2021)
4.9.5 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Revenue by Product
4.9.6 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application
4.9.7 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Revenue by Geographic Area
4.9.8 Avery Biomedical Recent Development
4.10 Greatbatch Medical
4.10.1 Greatbatch Medical Corporation Information
4.10.2 Greatbatch Medical Description, Business Overview
4.10.3 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Products Offered
4.10.4 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2016-2021)
4.10.5 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Revenue by Product
4.10.6 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application
4.10.7 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Revenue by Geographic Area
4.10.8 Greatbatch Medical Recent Development
5 Breakdown Data by Type
5.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2016-2027)
5.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2016-2021)
5.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Type (2022-2027)
5.1.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2016-2027)
5.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Forecast by Type (2016-2027)
5.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2016-2021)
5.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Forecast by Type (2022-2027)
5.2.3 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Type (2016-2027)
5.3 Neuromodulation Devices and Implantable Infusion Pumps Average Selling Price (ASP) by Type (2016-2027)
6 Breakdown Data by Application
6.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2016-2027)
6.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2016-2021)
6.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Application (2022-2027)
6.1.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2016-2027)
6.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Forecast by Application (2016-2027)
6.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2016-2021)
6.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Forecast by Application (2022-2027)
6.2.3 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Application (2016-2027)
6.3 Neuromodulation Devices and Implantable Infusion Pumps Average Selling Price (ASP) by Application (2016-2027)
7 North America
7.1 North America Neuromodulation Devices and Implantable Infusion Pumps Market Size YoY Growth 2016-2027
7.2 North America Neuromodulation Devices and Implantable Infusion Pumps Market Facts & Figures by Country
7.2.1 North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2016-2027)
7.2.2 North America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2016-2027)
7.3 North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Type
7.4 North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Market Size YoY Growth 2016-2027
8.2 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Market Facts & Figures by Region
8.2.1 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (2016-2027)
8.2.2 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region (2016-2027)
8.3 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales by Type
8.4 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales by Application
9 Europe
9.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Market Size YoY Growth 2016-2027
9.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Market Facts & Figures by Country
9.2.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2016-2027)
9.2.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2016-2027)
9.3 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Type
9.4 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Application
10 Latin America
10.1 Latin America Neuromodulation Devices and Implantable Infusion Pumps Market Size YoY Growth 2016-2027
10.2 Latin America Neuromodulation Devices and Implantable Infusion Pumps Market Facts & Figures by Country
10.2.1 Latin America Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2016-2027)
10.2.2 Latin America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2016-2027)
10.3 Latin America Neuromodulation Devices and Implantable Infusion Pumps Sales by Type
10.4 Latin America Neuromodulation Devices and Implantable Infusion Pumps Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Market Facts & Figures by Country
11.2.1 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2016-2027)
11.2.2 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2016-2027)
11.3 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Type
11.4 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Neuromodulation Devices and Implantable Infusion Pumps Supply Chain Analysis
12.2 Neuromodulation Devices and Implantable Infusion Pumps Key Raw Materials and Upstream Suppliers
12.3 Neuromodulation Devices and Implantable Infusion Pumps Clients Analysis
12.4 Neuromodulation Devices and Implantable Infusion Pumps Sales Channel and Sales Model Analysis
12.4.1 Neuromodulation Devices and Implantable Infusion Pumps Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Neuromodulation Devices and Implantable Infusion Pumps Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Neuromodulation Devices and Implantable Infusion Pumps Distributors
13 Market Dynamics
13.1 Neuromodulation Devices and Implantable Infusion Pumps Market Drivers
13.2 Neuromodulation Devices and Implantable Infusion Pumps Market Opportunities
13.3 Neuromodulation Devices and Implantable Infusion Pumps Market Challenges
13.4 Neuromodulation Devices and Implantable Infusion Pumps Market Restraints
13.5 Porter's Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Neuromodulation Devices and Implantable Infusion Pumps Market Size Growth Rate by Type (US$ Million): 2021 VS 2027
Table 2. Major Manufacturers of Spinal Cord Stimulation
Table 3. Major Manufacturers of Deep Brain Stimulation
Table 4. Major Manufacturers of Sacral Nerve Stimulation
Table 5. Major Manufacturers of Vagal Nerve Stimulation
Table 6. Major Manufacturers of Gastric Stimulation
Table 7. Major Manufacturers of Transcranial Magnetic Stimulation
Table 8. Major Manufacturers of Transcutaneous Electrical Stimulation
Table 9. Major Manufacturers of Other
Table 10. Global Neuromodulation Devices and Implantable Infusion Pumps Market Size Growth by Application (US$ Million): 2021 VS 2027
Table 11. Global Neuromodulation Devices and Implantable Infusion Pumps Market Size by Region (US$ Million): 2021 VS 2027
Table 12. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (2016-2021) & (Unit)
Table 13. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Region (2022-2027) & (Unit)
Table 14. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region (2016-2021) & (US$ Million)
Table 15. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 16. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Manufacturer (2016-2021) & (Unit)
Table 17. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Share by Manufacturer (2016-2021)
Table 18. Neuromodulation Devices and Implantable Infusion Pumps Revenue by Manufacturer (2016-2021) & (US$ Million)
Table 19. Neuromodulation Devices and Implantable Infusion Pumps Revenue Share by Manufacturer (2016-2021)
Table 20. Key Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Price (2016-2021) & (USD/Unit)
Table 21. Ranking of Global Top Neuromodulation Devices and Implantable Infusion Pumps Manufacturers by Revenue (US$ Million) in 2020
Table 22. Global Neuromodulation Devices and Implantable Infusion Pumps Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 23. Global Neuromodulation Devices and Implantable Infusion Pumps by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Neuromodulation Devices and Implantable Infusion Pumps as of 2020)
Table 24. Neuromodulation Devices and Implantable Infusion Pumps Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Product Type
Table 26. Date of International Manufacturers Enter into Neuromodulation Devices and Implantable Infusion Pumps Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Medtronic Corporation Information
Table 29. Medtronic Description and Business Overview
Table 30. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 31. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Product
Table 32. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million) and Market Share by Product
Table 33. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million) and Market Share by Application
Table 34. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million) and Market Share by Geographic Area
Table 35. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million) and Market Share by Sales Channel
Table 36. Medtronic Recent Development
Table 37. Boston Scientific Corporation Corporation Information
Table 38. Boston Scientific Corporation Description and Business Overview
Table 39. Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 40. Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Product
Table 41. Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million) and Market Share by Product
Table 42. Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million) and Market Share by Application
Table 43. Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million) and Market Share by Geographic Area
Table 44. Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million) and Market Share by Sales Channel
Table 45. Boston Scientific Corporation Recent Development
Table 46. St. Jude Medical Corporation Information
Table 47. St. Jude Medical Description and Business Overview
Table 48. St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 49. St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Product
Table 50. St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million) and Market Share by Product
Table 51. St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million) and Market Share by Application
Table 52. St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million) and Market Share by Geographic Area
Table 53. St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million) and Market Share by Sales Channel
Table 54. St. Jude Medical Recent Development
Table 55. Synapse Biomedical Corporation Information
Table 56. Synapse Biomedical Description and Business Overview
Table 57. Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 58. Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product
Table 59. Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million) and Market Share by Product
Table 60. Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million) and Market Share by Application
Table 61. Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million) and Market Share by Geographic Area
Table 62. Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million) and Market Share by Sales Channel
Table 63. Synapse Biomedical Recent Development
Table 64. Nevro Corporation Corporation Information
Table 65. Nevro Corporation Description and Business Overview
Table 66. Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 67. Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Product
Table 68. Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million) and Market Share by Product
Table 69. Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million) and Market Share by Application
Table 70. Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million) and Market Share by Geographic Area
Table 71. Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million) and Market Share by Sales Channel
Table 72. Nevro Corporation Recent Development
Table 73. Neuropace Corporation Information
Table 74. Neuropace Description and Business Overview
Table 75. Neuropace Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. Neuropace Neuromodulation Devices and Implantable Infusion Pumps Product
Table 77. Neuropace Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million) and Market Share by Product
Table 78. Neuropace Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million) and Market Share by Application
Table 79. Neuropace Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million) and Market Share by Geographic Area
Table 80. Neuropace Recent Development
Table 81. Cyberonics Corporation Information
Table 82. Cyberonics Description and Business Overview
Table 83. Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 84. Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Product
Table 85. Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million) and Market Share by Product
Table 86. Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million) and Market Share by Application
Table 87. Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million) and Market Share by Geographic Area
Table 88. Cyberonics Recent Development
Table 89. Autonomic Technologies Corporation Information
Table 90. Autonomic Technologies Description and Business Overview
Table 91. Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 92. Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Product
Table 93. Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million) and Market Share by Product
Table 94. Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million) and Market Share by Application
Table 95. Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million) and Market Share by Geographic Area
Table 96. Autonomic Technologies Recent Development
Table 97. Avery Biomedical Corporation Information
Table 98. Avery Biomedical Description and Business Overview
Table 99. Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 100. Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product
Table 101. Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million) and Market Share by Product
Table 102. Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million) and Market Share by Application
Table 103. Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million) and Market Share by Geographic Area
Table 104. Avery Biomedical Recent Development
Table 105. Greatbatch Medical Corporation Information
Table 106. Greatbatch Medical Description and Business Overview
Table 107. Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 108. Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Product
Table 109. Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million) and Market Share by Product
Table 110. Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million) and Market Share by Application
Table 111. Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million) and Market Share by Geographic Area
Table 112. Greatbatch Medical Recent Development
Table 113. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2016-2021) & (Unit)
Table 114. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Type (2022-2027) & (Unit)
Table 115. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2016-2021) & (US$ Million)
Table 116. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 117. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2016-2021) & (Unit)
Table 118. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Application (2022-2027) & (Unit)
Table 119. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2016-2021) & (US$ Million)
Table 120. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 121. North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2016-2021) & (Unit)
Table 122. North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2022-2027) & (Unit)
Table 123. North America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2016-2021) & (US$ Million)
Table 124. North America Neuromodulation Devices and Implantable Infusion

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs